Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventilator Associated Pneumonia: addition of Tobramycin inhalation to standard IV antibiotics
2014-001406-17Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tobramycin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Erasmus MC. Primary endpoint: Clinical nonresponse. Started Aug 2014; status: active.
02
Drugs
tobramycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2014-001406-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001406-17.